I am...
- All
- ECD
- HLH/FEL/FHL
- JXG
- LCH
- Rare Histiocytic Disorders and Other Topics
- RDD
Investigations into the Clinical and Molecular Pathogenesis of XIAP Deficiency
Principal Investigator and Co-Investigators Rebecca Marsh MD (PI); Jack J. H. Bleesing MD, PhD; Kimberly Risma MD,…
A Transgenic Mouse Model Mimicking Abnormal Langerhans Cell Trafficking in Langerhans Cell Histiocytosis
Principal Investigator and Co-Investigator Barrett J. Rollins MD, PhD (PI); Barbara Brandner PhD; Gayane Badalian MD, PhD…
Role of the Granzyme Inhibitor Proteinase Inhibitor-9 (PI-9) in Langerhans Cell Histiocytosis
Principal Investigator Carl Friedrich Classen MD University Childrens Hospital Rostock – Duisburg, Germany Date of Award December…
Mechanisms of IL-17A-Dependent Dendritic Cell Long-Term Survival and Fusion in Langerhans Cell Histiocytosis
Principal Investigator Christine Delprat MD, PhD INSERM – Lyon, France Date of Award December 2007 Amount of…
Lymphocyte Trafficking in Langerhans Cell Histiocytosis
Principal Investigator and Co-Investigator Kenneth McClain MD, PhD (PI) and Carl Allen MD, PhD Texas Children’s Cancer…
Ganglioside-Induced Defective Granule Exocytosis-Mediated Cytotoxicity in Hemophagocytic Lymphohistiocytosis
Principal Investigator Sasa Radoja PhD Children’s National Medical Center – Washington, District of Columbia USA Date of…
Biomarker Monitoring of Central Nervous System Disease in Langerhans Cell Histiocytosis
Principal Investigator Jan-Inge Henter MD, PhD Karolinska Institutet – Stockholm, Sweden Date of Award December 2007 Amount…